Agenda and minutes
PDF 153 KBVenue: Committee Room 1 - Senedd. View directions
Contact: Llinos Madeley
| Expected timing | No. | Item |
|---|---|---|
|
Transcript View the meeting transcript. |
||
|
Introductions, apologies and substitutions Minutes: 1.1 Apologies were received from Darren Millar, Gwyn Price
and Kirsty Williams. |
||
(09:15 - 10:05) |
Inquiry into access to medical technologies in Wales: Evidence session 8 Cancer
Research UK Emma Greenwood, Head of Policy Development, Cancer Research
UK Clare Bath, Public Affairs Officer for Wales Dr Tom Crosby, Medical Clinical Director of Velindre Cancer
Centre, and the Medical Director of the South Wales Cancer Network Bernadette McCarthy, Radiotherapy Manager, Velindre Cancer
Centre Supporting documents: Minutes: 2.1. The witnesses responded to questions from Committee
members. 2.2 Emma Greenwood informed the Committee of recent work
undertaken in collaboration between Cancer Research UK and NHS England which
asked relevant industry groups how they envisaged the field of radiography in
10 years. Ms Greenwood agreed to share information on this work with the
Committee. |
|
(10:05 - 10:50) |
Inquiry into access to medical technologies in Wales: Evidence session 9 Genetic
Alliance UK Buddug Cope, Director of Development for Genetic Alliance UK Emma Hughes, Development Officer for Genetic Alliance UK Hayley Norris, Patient representative Supporting documents: Minutes: 3.1 The witnesses responded to questions from Committee
members. 3.2 Buddug Cope agreed to provide the Committee with
information regarding the link between the NICE health technology programme and
the UK Genetic Testing Network (UKGTN). 3.3 Ms Cope also agreed to provide the Committee with further
clarification regarding the relationship between the approval of new tests by
UKGTN and their subsequent commissioning by NHS Scotland. |
|
(11:00 - 12:00) |
Inquiry into access to medical technologies in Wales: Evidence session 10 MediWales Gwyn Tudor, Forum Manager Supporting documents: Minutes: 4.1. The witnesses responded to questions from Committee
members. 4.1 The Committee agreed to consider items 6, 7 and 8 before
the consideration of item 5. |
|
(13.00 - 14.00) |
Inquiry into access to medical technologies in Wales: Evidence session 11 Professor Carl Heneghan, Centre for Evidence-Based Medicine,
Oxford University South
East Wales Academic Health Science Partnership Dr Corinne Squire, Manager West of
England Academic Health Science Network Lars Sundstrom, Director of Enterprise and Translation Deborah Evans, Managing Director Supporting documents:
Minutes: 5.1. The witnesses responded to questions from Committee
members. 5.2 Lars Sundstrom, West of England Academic Health Science
Network, agreed to provide a note on the new system that has been introduced in
England (that is available to Welsh organisations) which allows access to funds
and provides a method of commissioning research and development through the
healthcare system. |
|
|
Papers to Note Supporting documents:
Minutes: 6.1 The Committee noted the minutes of the previous meetings. |
||
|
Letter from the Chief Nursing Officer in relation to action points arising from the Committee meeting of 30 January 2014 Supporting documents:
Minutes: 6a.1 The Committee noted the letter from the Chief Nursing
Officer. |
||
|
Motion under Standing Order 17.42 to resolve to exclude the public from the meeting for the following business: Item 8. Minutes: 7.1 The Committee agreed the motion to consider item 8 in
private. |
||
(14.05 - 14.20) |
Consideration of the Minister for Health and Social Services' response to the Committee's letter regarding the follow-up inquiry into stroke risk reduction Minutes: 8.1 The Committee discussed the letter from the Minister for
Health and Social Services regarding the follow-up inquiry into stroke risk
reduction. 8.2 The Committee agreed that it would discuss actions in its
public meeting on 20 March 2014. |